FTC chair blames hospital price increases on consolidation

John Gregory | | Health Exec | Policy & Regulations

After losing a court battle to block a health system merger in Pennsylvania, Federal Trade Commission Chairwoman Edith Ramirez criticized the growing number of hospital mergers in a May 13 speech, according to The Washington Post.

To read more about her critiques of consolidation’s effects on quality and price and the response from the American Hospital Association, click on the link below: 

This health-care trend could make your hospital stay $2,000 more expensive

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Related Content

Trump signs executive order to withdraw U.S. from the World Health Organization
DOJ sues Walgreens for allegedly filling ‘millions’ of illegal prescriptions
Another insurer sues CMS over star ratings, citing contractor error
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say
DEA wants to permanently anchor some COVID-era prescription regulations
FDA regulator examines AI's growing influence in cardiology

Around the web

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.